Observations and findings during the development of a subnormothermic/normothermic long-term ex vivo liver perfusion machine

被引:3
|
作者
Schuler, Martin J. [1 ]
Becker, Dustin [1 ]
Mueller, Matteo [2 ]
Bautista Borrego, Lucia [2 ]
Mancina, Leandro [2 ]
Huwyler, Florian [3 ]
Binz, Jonas [1 ]
Hagedorn, Catherine [2 ]
Schaer, Beatrice [4 ]
Gygax, Erich [5 ]
Weisskopf, Miriam [6 ]
Sousa Da Silva, Richard Xavier [2 ]
Antunes Crisostomo, Joao Miguel [1 ]
Dutkowski, Philipp [2 ]
Rudolf von Rohr, Philipp [7 ]
Clavien, Pierre-Alain [2 ]
Tibbitt, Mark W. [3 ]
Eshmuminov, Dilmurodjon [2 ]
Hefti, Max [1 ]
机构
[1] Univ Zurich, Wyss Zurich ETH Zurich, CH-8092 Zurich, Switzerland
[2] Univ Hosp Zurich, Dept Surg, Swiss Hepato Pancreato Biliary & Transplantat Ctr, Zurich, Switzerland
[3] Swiss Fed Inst Technol, Dept Mech & Proc Engn, Macromol Engn Lab, Zurich, Switzerland
[4] Securecell AG, Entwicklung Biomed Anwendungen, Urdorf, Switzerland
[5] Fumed AG, Forsch & Entwicklung, Muri, Switzerland
[6] Univ Zurich, Univ Zurich Hosp, Surg Res Ctr, Zurich, Switzerland
[7] Swiss Fed Inst Technol, Dept Mech & Proc Engn, Transport Proc & React Lab, Zurich, Switzerland
关键词
clearance; free hemoglobin; hemolysis; lactate; liver perfusion; long-term perfusion; perfusion parameters; subnormothermic; normothermic perfusion; CARDIOPULMONARY BYPASS; BLOOD; TRANSPLANTATION; PRESERVATION; METABOLISM; PULSATILE; MICROCIRCULATION; HEMOGLOBIN; DELIVERY; ORGAN;
D O I
10.1111/aor.14403
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Background Ex situliver machine perfusion at subnormothermic/normothermic temperature isincreasingly applied in the field of transplantation to store and evaluateorgans on the machine prior transplantation. Currently, various perfusionconcepts are in clinical and preclinical applications. Over the last 6 years ina multidisciplinary team, a novel blood based perfusion technology wasdeveloped to keep a liver alive and metabolically active outside of the bodyfor at least one week. Methods Within thismanuscript, we present and compare three scenarios (Group 1, 2 and 3) we werefacing during our research and development (R&D) process, mainly linked tothe measurement of free hemoglobin and lactate in the blood based perfusate. Apartfrom their proven value in liver viability assessment (ex situ), these twoparameters are also helpful in R&D of a long-term liver perfusion machine and moreover supportive in the biomedical engineering process. Results Group 1 ("good" liver on the perfusion machine) represents the best liver clearance capacity for lactate and free hemoglobin wehave observed. In contrast to Group 2 ("poor" liver on the perfusion machine), that has shown the worst clearance capacity for free hemoglobin. Astonishingly,also for Group 2, lactate is cleared till the first day of perfusion andafterwards, rising lactate values are detected due to the poor quality of theliver. These two perfusate parametersclearly highlight the impact of the organ quality/viability on the perfusion process. Whereas Group 3 is a perfusion utilizing a blood loop only (without a liver). Conclusion Knowing the feasible ranges (upper- and lower bound) and the courseover time of free hemoglobin and lactate is helpful to evaluate the quality ofthe organ perfusion itself and the maturity of the developed perfusion device. Freehemoglobin in the perfusate is linked to the rate of hemolysis that indicates how optimizing (gentle blood handling, minimizing hemolysis) the perfusion machine actually is. Generally, a reduced lactate clearancecapacity can be an indication for technical problems linked to the blood supplyof the liver and therefore helps to monitor the perfusion experiments.Moreover, the possibility is given to compare, evaluate and optimize developed liverperfusion systems based on the given ranges for these two parameters. Otherresearch groups can compare/quantify their perfusate (blood) parameters withthe ones in this manuscript. The presented data, findings and recommendations willfinally support other researchers in developing their own perfusion machine ormodifying commercially availableperfusion devices according to their needs.
引用
收藏
页码:317 / 329
页数:13
相关论文
共 50 条
  • [41] No need for complex blood purification systems for renal replacement therapy during long-term liver normothermic machine perfusion
    Lascaris, Bianca
    Nijsten, Maarten W. N.
    de Meijer, Vincent E.
    JOURNAL OF HEPATOLOGY, 2024, 81 (06) : e287 - e289
  • [42] LONG-TERM MAINTENANCE OF HUMAN LIVER TISSUE BY EX-VIVO PERFUSION OF LIVER SECTIONS
    Schreiter, T.
    Sowa, J. -P.
    Mathe, Z.
    Treckmann, J.
    Broecker-Preuss, M.
    Baba, H. A.
    Gieseler, R. K.
    Gerken, G.
    Canbay, A.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S70 - S70
  • [43] FEASIBILITY OF DELIVERING CELL THERAPY DURING KIDNEY EX VIVO NORMOTHERMIC MACHINE PERFUSION
    Thompson, E. R.
    Ibrahim, I. K.
    Bates, L.
    Sewpaul, A.
    Stenberg, B.
    McNeill, A.
    Scott, W. E.
    Roobrouck, V.
    Ting, A.
    Ali, S.
    Sheerin, N.
    Fisher, A. J.
    Wilson, C. H.
    CYTOTHERAPY, 2018, 20 (05) : S117 - S118
  • [44] Inulin Clearance During Ex vivo Normothermic Machine Perfusion as a Marker of Renal Function
    Markgraf, Wenke
    Muehle, Richard
    Lilienthal, Jannis
    Kromnik, Susanne
    Thiele, Christine
    Malberg, Hagen
    Janssen, Martin
    Putz, Juliane
    ASAIO JOURNAL, 2022, 68 (09) : 1211 - 1218
  • [45] Normothermic machine perfusion system satisfying oxygen demand of liver could maintain liver function more than subnormothermic machine perfusion
    Yoshida, Kozue
    Nakamura, Shunsuke
    Sakamoto, Hiroki
    Kondo, Mika
    Chouno, Takehiro
    Ikegami, Yasuhiro
    Shirakigawa, Nana
    Mizumoto, Hiroshi
    Yamashita, Yo-ichi
    Baba, Hideo
    Ijima, Hiroyuki
    JOURNAL OF BIOSCIENCE AND BIOENGINEERING, 2021, 131 (01) : 107 - 113
  • [46] A Small Animal Model of Ex Vivo Normothermic Liver Perfusion
    Beal, Eliza W.
    Dumond, Curtis
    Kim, Jung-Lye
    Akateh, Clifford
    Eren, Emre
    Maynard, Katelyn
    Sen, Chandan K.
    Zweier, Jay L.
    Washburn, Kenneth
    Whitson, Bryan A.
    Black, Sylvester M.
    JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2018, (136):
  • [47] DEVELOPMENT OF SUSTAINABLE EX-VIVO NORMOTHERMIC LIVER PERFUSION PLATFORM FOR RESEARCH PURPOSES
    Mirle, Vikranth R.
    Piech, Ryan
    JOURNAL OF INVESTIGATIVE MEDICINE, 2021, 69 (05) : 1069 - 1069
  • [48] Long-Term Perfusion of the Liver Outside the Body: Warming Up for Ex Vivo Therapies?
    Schurink, Ivo J.
    Willemse, Jorke
    Verstegen, Monique M. A.
    van Der Laan, Luc J. W.
    de Jonge, Jeroen
    HEPATOLOGY, 2020, 72 (04) : 1485 - 1487
  • [49] LPotential of mitochondrial dysfunction biomarkers during ex-vivo normothermic liver perfusion
    Ali, K.
    Liu, Q.
    Cazzaniga, B.
    Raj, R.
    Tuul, M.
    Uso, T. Diago
    Fujiki, M.
    Aucejo, F.
    Eghtesad, B.
    D'Amico, G.
    Kwon, C. H. D.
    Chaudhry, S.
    Pita, A.
    Kim, J.
    Fairchild, R.
    Doi, J.
    Khalil, M.
    Fernandes, E.
    Kusakabe, J.
    Calderon, E.
    Miller, C.
    Schlegel, A.
    Hashimoto, K.
    Quintini, C.
    TRANSPLANTATION, 2023, 107 (09) : 90 - 90
  • [50] Immune Effects of Extracellular Vesicles Generated During Normothermic Ex Vivo Liver Perfusion
    Jennings, H.
    McMorrow, S.
    Carlson, K. N.
    Chlebeck, P.
    Verhoven, B. M.
    Al-Adra, D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (06) : S920 - S920